ABVC BioPharma, Inc.

US$0.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ABVCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (69.86%)
Biotechnology
Beta (5Y) 0.50
PE TTM —
TSR TTM (65.40%)
Mkt cap US$25.15M
ROIC (30.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.23
27.13%
(94.08%)
Hold 4|12|5|7|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
9.56%
1.62%
8.53%
0.56%
Revenue$M
1.464
1.433
1.391
1.355
0.97%
0.14%
(5.76%)
(9.37%)
Peers (US$25.15M)
Cap (US$)
PE
25.02M
—
Capital
TTM
5Y
10Y
Leveragex
1.494
1.238
1.317
EBIT/Intx
4.462
0.366
0.386
Own earn%
(20.30)
(69.02)
(69.67)
Sh yield%
19.93
48.13
45.56
Owners
Insiders/Inst%
3.29
82.55
Short interest%
1.16
SBC / revenue%
4.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
6–13
$1 testx
—
Incr. ROIC%
6